Repression of DNA repair mechanisms in IRF-4-expressing and HTLV-I-infected T lymphocytes

Journal of Interferon and Cytokine Research

Volumn 25, Issue 1, 2005, Pages 43-51

  Mamane, Yaël ^a,b   Loignon, Martin ^a   Palmer, Jennifer ^a,b   Hernandez, Eduardo ^a   Césaire, Raymond ^c   Alaoui Jamali, Moulay ^a   Hiscott, John ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; INTERFERON REGULATORY FACTOR 4; RAD51 PROTEIN;

ARTICLE; CELL PROLIFERATION; DNA REPAIR; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMIA CELL LINE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 12144267407     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2005.25.43     Document Type: Article

References (54)

1. TSUKASAKI, K. (2002). Genetic instability of adult T-cell leukemia/lymphoma by comparative genomic hybridization analysis. J. Clin. Immunol. 22, 57-63.
2. EDLICH, R.F., ARNETTE, J.A., and WILLIAMS, F.M. (2000). Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J. Emerg. Med. 18, 109-119.
3. OHSHIMA, K., SUZUMIYA, J., SATO, K., KANDA, M., SIMAZAKI, T., KAWASAKI, C., HARAOKA, S., and KIKUCHI, M. (1999). Survival of patients with HTLV-I-associated lymph node lesions. J. Pathol. 189, 539-545.
4. YOSHIDA, M. (2001). Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu. Rev. Immunol. 19, 475-496.
5. YAO, J., and WIGDAHL, B. (2000). Human T cell lymphotropic virus type I genomic expression and impact on intracellular signaling pathways during neurodegenerative disease and leukemia. Front. Biosci. 5, D138-D168.
6. JIN, D.Y., SPENCER, F., and JEANG, K.T. (1998). Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93, 81-91.
7. NEUVEUT, C., and JEANG, K.T. (2002). Cell cycle dysregulation by HTLV-I, role of the tax oncoprotein. Front. Biosci. 7, d157-d163.
8. SHARMA, S., GRANDVAUX, N., MAMANE, Y., GENIN, P., AZIMI, N., WALDMANN, T., and HISCOTT, J. (2002). Regulation of IFN regulatory factor 4 expression in human T cell leukemia virus-I-transformed T cells. J. Immunol. 169, 3120-3130.
9. GRUMONT, R.J., and GERONDAKIS, S. (2000). Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB. J. Exp. Med. 191, 1281-1292.
10. SHARMA, S., MAMANE, Y., GRANDVAUX, N., BARTLETT, J., PETROPOULOS, L., LIN, R., and HISCOTT, J. (2000). Activation and regulation of interferon regulatory factor 4 in HTLV type I-infected T lymphocytes. AIDS Res. Hum. Retrovir. 16, 1613-1622.
11. MITTRUCKER, H.W., MATSUYAMA, T., GROSSMAN, A., KUNDIG, T.M., POTTER, J., SHAHINIAN, A., WAKEHAM, A., PATTERSON, B., OHASHI, P.S., and MAK, T.W. (1997). Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science. 275, 540-543.
12. YAMAGATA, T., NISHIDA, J., TANAKA, S., SAKAI, R., MITANI, K., YOSHIDA, M., TANIGUCHI, T., YAZAKI, Y., and HIRAI, H. (1996). A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol. Cell. Biol. 16, 1283-1294.
13. IMAIZUMI, Y., KOHNO, T., YAMADA, Y., IKEDA, S., TANAKA, Y., TOMONAGA M., and MATSUYAMA, T. (2001). Possible involvement of interferon regulatory factor 4 (IRF4) in a clinical subtype of adult T-cell leukemia. Jpn. J. Cancer Res. 92, 1284-1292.
14. IIDA, S., RAO, P.H., BUTLER, M., CORRADINI, P., BOCCADORO, M., KLEIN, B., CHAGANTI, R.S., and DALLA-FAVERA, R. (1997). Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat. Genet. 17, 226-230.
15. SCHMIDT, M., HOCHHAUS, A., KONIG-MEREDIZ, S.A., BRENDEL, C., PROBA, J., HOPPE, G.J., WITTIG, B., EHNINGER, G., HEHLMANN, R., and NEUBAUER, A. (2000). Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy. J. Clin. Oncol. 18, 3331-3338.
16. ARGUELLO, M., SGARBANTI, M., HERNANDEZ, E., MAMANE, Y., SHARMA, S., SERVANT, M., LIN, R., and HISCOTT, J. (2003). Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines. Oncogene 22, 964-973.
17. CARBONE, A., GLOGHINI, A., COZZI, M.R., CAPELLO, D., STEFFAN, A., MONINI, P., DE MARCO, L., and GAIDANO, G. (2000). Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis. Br. J. Haematol. 111, 247-257.
18. CARBONE, A., GLOGHINI, A., LAROCCA, L.M., CAPELLO, D., PIERCONTI, F., CANZONIERI, V., TIRELLI, U., DALLA-FAVERA, R., and GAIDANO, G. (2001). Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood 97, 744-751.
19. MAMANE, Y., GRANDVAUX, N., HERNANDEZ, E., SHARMA, S., INNOCENTE, S.A., LEE, J.M., AZIMI, N., LIN, R., and HISCOTT, J. (2002). Repression of IRF-4 target genes in human T cell leukemia virus-1 infection. Oncogene 21, 6751-6765.
20. HAYAMI, Y., KOMATSU, H., IIDA, S., UTSUNOMIYA, A., HANADA, S., HUA, X.J., HUIPING, N., HARADA, S., TSUBOI, K., BANNO, S., WAKITA, A., KATO, T., and UEDA, R. (1999). Microsatellite instability as a potential marker for poor prognosis in adult T cell leukemia/lymphoma. Leuk. Lymphoma 32, 345-349.
21. NYBERG, K.A., MICHELSON, R.J., PUTNAM, C.W., and WEINERT, T.A. (2002). Toward maintaining the genome, DNA damage and replication checkpoints. Annu. Rev. Genet. 36, 617-656.
22. HOEIJMAKERS, J.H. (2001). Genome maintenance mechanisms for preventing cancer. Nature 411, 366-374.
23. SIEBER, O.M., HEINIMANN, K., and TOMLINSON, I.P. (2003). Genomic instability - the engine of tumorigenesis? Nat. Rev. Cancer 3, 701-708.
24. CLEAVER, J.E., and CROWLEY, E. (2002). UV damage, DNA repair and skin carcinogenesis. Front. Biosci. 7, d1024-1043.
25. HEINEN, C.D., SCHMUTTE, C., and FISHEL, R. (2002). DNA repair and tumorigenesis: lessons from hereditary cancer syndromes. Cancer Biol. Ther. 1, 477-485.
26. FRIEDBERG, E.C. (2001). How nucleotide excision repair protects against cancer. Nat. Rev. Cancer 1, 22-33.
27. D'ANDREA, A.D., and GROMPE, M. (2003). The Fanconi anaemia/BRCA pathway. Nat. Rev. Cancer 3, 23-34.
28. D'ANDREA, A.D. (2003). The Fanconi road to cancer. Genes Dev. 17, 1933-1936.
29. KHANNA, K.K., and JACKSON, S.P. (2001). DNA double-strand breaks, signaling, repair and the cancer connection. Nat. Genet. 27, 247-254.
30. OLSEN, J.H., HAHNEMANN, J.M., BORRESEN-DALE, A.L., BRONDUM-NIELSEN, K., HAMMARSTROM, L., KLEINERMAN, R., KAARIAINEN, H., LONNQVIST, T., SANKILA, R., SEERSHOLM, N., TRETLI, S., YUEN, J., BOICE, Jr., J.D., and TUCKER, M. (2001). Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries. J. Natl. Cancer Inst. 93, 121-127.
31. DUKER, N.J. (2002). Chromosome breakage syndromes and cancer. Am. J. Med. Genet. 115, 125-129.
32. LUNDIN, C., SCHULTZ, N., ARNAUDEAU, C., MOHINDRA, A., HANSEN, L.T., and HELLEDAY, T. (2003). RAD51 is involved in repair of damage associated with DNA replication in mammalian cells. J. Mol. Biol. 328, 521-535.
33. BANATH, J.P., KIM, A., and OLIVE, P.L. (2001). Overnight lysis improves the efficiency of detection of DNA damage in the alkaline comet assay. Radiat. Res. 155, 564-571.
34. HELMA, C., and UHL, M. (2000). A public domain image-analysis program for the single-cell gel-electrophoresis (comet) assay. Mutat. Res. 466, 9-15.
35. TAYLOR, R.M., MOORE, D.J., WHITEHOUSE, J., JOHNSON, P., and CALDECOTT, K.W. (2000). A cell cycle-specific requirement for the XRCC1 BRCT II domain during mammalian DNA strand break repair. Mol. Cell. Biol. 20, 735-740.
36. MARSIN, S., VIDAL, A.E., SOSSOU, M., MENISSIER-DE MURCIA, J., LE PAGE, F., BOITEUX, S., DE MURCIA, G., and RADICELLA, J.P. (2003). Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1. J. Biol. Chem. 278, 44068-44074.
37. SCHULER, M., and GREEN, D.R. (2001). Mechanisms of p53-dependent apoptosis. Biochem. Soc. Trans. 29, 684-688.
38. HATTA, Y., and KOEFFLER, H.P. (2002). Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL). Leukemia 16, 1069-1085.
39. NEWCOMB, E.W. (1995). p53 gene mutations in lymphoid diseases and their possible relevance to drug resistance. Leuk. Lymphoma 17, 211-221.
40. HATTA, Y., YAMADA, Y., TOMONAGA, M., SAID, J.W., MIYOSI, I., and KOEFFLER, H.P. (1998). Allelotype analysis of adult T-cell leukemia. Blood 92, 2113-2117.
41. ARIUMI, Y., KAIDA, A., LIN, J.Y., HIROTA, M., MASUI, O., YAMAOKA, S., TAYA, Y., and SHIMOTOHNO, K. (2000). HTLV-1 tax oncoprotein represses the p53-mediated transactivation function through coactivator CBP sequestration. Oncogene. 19, 1491-1499.
42. UITTENBOGAARD, M.N., GIEBLER, H.A., REISMAN, D., and NYBORG, J.K. (1995). Transcriptional repression of p53 by human T-cell leukemia virus type I Tax protein. J. Biol. Chem. 270, 28503-28506.
43. PISE-MASISON, C.A., CHOI, K.S., RADONOVICH, M., DITTMER, J., KIM, S.J., and BRADY, J.N. (1998). Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein. J. Virol. 72, 1165-1170.
44. 1 arrest and enhances apoptosis in p53 null cells. Virology 305, 229-239.
45. KAO, S.Y., and MARRIOTT, S.J. (1999). Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 Tax protein. J. Virol. 73, 4299-4304.
46. PHILPOTT, S.M., and BUEHRING, G.C. (1999). Defective DNA repair in cells with human T-cell leukemia/bovine leukemia viruses, role of tax gene. J. Natl. Cancer Inst. 91, 933-942.
47. HAOUDI, A., DANIELS, R.C., WONG, E., KUPFER, G., and SEMMES, O.J. (2003). Human T-cell leukemia virus-I tax oncoprotein functionally targets a subnuclear complex involved in cellular DNA damage-response. J. Biol. Chem. 278, 37736-37744.
48. DE LA FUENTE, C., WANG, L., WANG, D., DENG, L., WU, K., LI, H., STEIN, L.D., DENNY, T., COFFMAN, F., KEHN, K., BAYLOR, S., MADDUKURI, A., PUMFERY, A., and KASHANCHI, F. (2003). Paradoxical effects of a stress signal on pro- and anti-apoptotic machinery in HTLV-1 Tax expressing cells. Mol. Cell. Biochem. 245, 99-113.
49. LIU, B., LIANG, M.H., KUO, Y.L., LIAO, W., BOROS, I., KLEINBERGER, T., BLANCATO, J., and GIAM, C.Z. (2003). Human T-lymphotropic virus type 1 oncoprotein tax promotes unscheduled degradation of Pds1p/securin and Clb2p/cyclin B1 and causes chromosomal instability. Mol. Cell. Biol. 23, 5269-5281.
50. MULLOY, J.C., KISLYAKOVA, T., CERESETO, A., CASARETO, L., LOMONICO, A., FULLEN, J., LORENZI, M.V., CARA, A., NICOT, C., GIAM, C., and FRANCHINI, G. (1998). Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J. Virol. 72, 8852-8860.
51. MANEL, N., KIM, F.J., KINET, S., TAYLOR, N., SITBON, M., and BATTINI, J.L. (2003). The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115, 449-459.
52. PERNIS, A.B. (2002). The role of IRF-4 in B and T cell activation and differentiation. J. Interferon Cytokine Res. 22, 111-120.
53. MAMANE, Y., HEYLBROECK, C., GENIN, P., ALGARTE, M., SERVANT, M.J., LEPAGE, C., DELUCA, C., KWON, H., LIN, R., and HISCOTT, J. (1999). Interferon regulatory factors, the next generation. Gene 237, 1-14.
54. MAJONE, F., and JEANG, K.-T. (2000). Clastogenic effect of the human T cell leukemia virus type 1 Tax oncoprotein correlates with unstabilized DNA breaks. J. Biol. Chem. 275, 32906-32910.